Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Telogen effluvium is the most common hair loss in women, often linked to low iron, while tight hairstyles and headscarves increase traction alopecia risk.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Insomnia may increase alopecia areata risk, but more research is needed.

Low serum ferritin is linked to hair loss in women.

Hair loss negatively impacts quality of life, and psychological support can help.

Low-dose oral minoxidil significantly improves hair density in non-scarring alopecia.

Eating more antioxidant-rich foods and less alcohol may help reduce hair loss.

Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.

New treatments are needed for non-scarring alopecia due to current limitations.

Current treatments for non-scarring alopecia have limited effectiveness and side effects, while natural remedies may offer safer alternatives but need more research.

Vitamin D deficiency is common in children with non-scarring alopecia, and managing it may help treatment.

Tumid lupus erythematosus can cause non-scarring hair loss on the scalp and requires careful diagnosis.

Tailored combination therapy improves non-scarring alopecia outcomes.

Androgenetic alopecia is the most common type of non-scarring hair loss, especially in young males, and early diagnosis and treatment are important.

Teledermatology effectively diagnoses and manages non-scarring alopecia remotely.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

Iron infusions can help improve hair loss in patients who can't take oral iron supplements.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Autologous follicular stem cells improved hair loss in 57% of patients.

Higher levels of β-carotene and vitamin E may help prevent certain types of hair loss.

The treatment led to significant hair regrowth in a lupus patient.

The patient with lupus and Degos' disease showed significant improvement with treatment.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

Digital video microscopy is a useful non-invasive tool for diagnosing non-scarring alopecia.

The botanical shampoo with Morus alba root extract is safe and effective for treating hair loss.